Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | GAD2 |
| Upstream (Parents) |
|---|
| (<<) TSPAN5 → GAD2 |
| (<<) DSTYK → GAD2 |
| (<<) GFPT1 → GAD2 |
| (<<) DAB1 → GAD2 |
| (<<) RBM3 → GAD2 |
| (<<) RICH2 → GAD2 |
| (<<) C8orf33 → GAD2 |
| (<<) PELO → GAD2 |
| (<<) FLG → GAD2 |
| (<<) GP2 → GAD2 |
| Downstream (Children) |
|---|
| GAD2 → RBM3 (>>) |
| GAD2 → FLG (>>) |
| GAD2 → GP2 (>>) |
